Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) is -81.96% lower on its value in year-to-date trading and has touched a low of $0.53 and a high of $7.11 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IRWD stock was last observed hovering at around $0.59 in the last trading session, with the day’s gains setting it 0.21%.
Currently trading at $0.80, the stock is 29.08% and -2.68% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 12.31 million and changing 36.34% at the moment leaves the stock -71.65% off its SMA200. IRWD registered -87.61% loss for a year compared to 6-month loss of -76.07%. The firm has a 50-day simple moving average (SMA 50) of $0.8208 and a 200-day simple moving average (SMA200) of $2.819.
The stock witnessed a 12.68% gain in the last 1 month and extending the period to 3 months gives it a -46.01%, and is 31.02% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 16.77% over the week and 9.51% over the month.
Ironwood Pharmaceuticals Inc (IRWD) has around 253 employees, a market worth around $129.31M and $317.68M in sales. Fwd P/E is 2.26. Profit margin for the company is -9.89%. Distance from 52-week low is 51.60% and -88.75% from its 52-week high. The company has generated returns on investments over the last 12 months (-12.00%).
with sales reaching $62.02M over the same period.The EPS is expected to grow by 1644.75% this year, but quarterly earnings will post -23.37% year-over-year. Quarterly sales are estimated to shrink -34.30% in year-over-year returns.
Ironwood Pharmaceuticals Inc (IRWD) Top Institutional Holders
285.0 institutions hold shares in Ironwood Pharmaceuticals Inc (IRWD), with institutional investors hold 100.05% of the company’s shares. The shares outstanding are 161.81M, and float is at 156.14M with Short Float at 5.42%. Institutions hold 97.52% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 22.88 million shares valued at $149.16 million. The investor’s holdings represent 14.3868% of the IRWD Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 21.56 million shares valued at $140.59 million to account for 13.5607 of the shares outstanding. The other top investors are SARISSA CAPITAL MANAGEMENT LP which holds 16.39 million shares representing 10.3073% and valued at over $106.86 million, while UBS GROUP AG holds 7.0436 of the shares totaling 11.2 million with a market value of $73.03 million.
Ironwood Pharmaceuticals Inc (IRWD) Insider Activity
The most recent transaction is an insider sale by MCCOURT Thomas A, the company’s Chief Executive Officer. SEC filings show that MCCOURT Thomas A sold 13,353 shares of the company’s common stock on May 16 ’25 at a price of $0.58 per share for a total of $7745.0. Following the sale, the insider now owns 1.15 million shares.
Ironwood Pharmaceuticals Inc disclosed in a document filed with the SEC on May 16 ’25 that Gaskins Tammi L (Chief Commercial Officer) sold a total of 2,563 shares of the company’s common stock. The trade occurred on May 16 ’25 and was made at $0.58 per share for $1487.0. Following the transaction, the insider now directly holds 0.24 million shares of the IRWD stock.
Still, SEC filings show that on May 19 ’25, MCCOURT Thomas A (Officer) Proposed Sale 14,661 shares at an average price of $0.59 for $8650.0. The insider now directly holds shares of Ironwood Pharmaceuticals Inc (IRWD).
